Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 10/2010

01.10.2010 | Article

Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland

verfasst von: T. Siljander, O. Lyytikäinen, S. Vähäkuopus, M. Snellman, J. Jalava, J. Vuopio

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

In 2006, Finnish nationwide surveillance showed an increase of invasive group A streptococcal (iGAS) disease and clinicians were alarmed by severe disease manifestations, prompting the investigation of recent trends and outcome for iGAS. A case of iGAS was defined as Streptococcus pyogenes isolated from blood or cerebrospinal fluid. Cases during 1998–2007 and isolates during 2004–2007 were included. Case-patients’ 7-day outcome was available for 2004–2007. Isolates were emm typed. A total of 1,318 cases of iGAS were identified. The average annual incidence was 2.5/100,000 population. The rate was higher in males than females in persons aged 45–64 years, but lower in persons aged 25–34 years. The annual incidence was highest in 2007 (3.9/100,000). Occasional peaks occurred during midwinter and midsummer. The most common emm types were 28 (21%), 1 (16%), 84 (10%), 75 (7%) and 89 (6%). During 2004–2007, emm1 replaced emm28 as the most predominant type. The overall case fatality was 8%. Cases with emm1 were associated with high case fatality (14% vs. 8% in other types; p < 0.02); that of emm28 infections was 2% (p < 0.01). Changes in emm type prevalence influenced incidence and case fatality. Differences in age- and sex-specific incidence and seasonal patterns suggest variations in predisposing factors and underlying conditions.
Literatur
1.
Zurück zum Zitat Schwartz B, Facklam RR, Breiman RF (1990) Changing epidemiology of group A streptococcal infection in the USA. Lancet 336:1167–1171CrossRefPubMed Schwartz B, Facklam RR, Breiman RF (1990) Changing epidemiology of group A streptococcal infection in the USA. Lancet 336:1167–1171CrossRefPubMed
2.
Zurück zum Zitat Martin DR, Single LA (1993) Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis 167:1112–1117PubMed Martin DR, Single LA (1993) Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis 167:1112–1117PubMed
3.
Zurück zum Zitat Strömberg A, Romanus V, Burman LG (1991) Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis 164:595–598PubMed Strömberg A, Romanus V, Burman LG (1991) Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis 164:595–598PubMed
4.
Zurück zum Zitat Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalén C, Jasir A (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46:2359–2367CrossRefPubMed Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalén C, Jasir A (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46:2359–2367CrossRefPubMed
5.
Zurück zum Zitat O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C (2007) The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis 45:853–862CrossRefPubMed O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C (2007) The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis 45:853–862CrossRefPubMed
6.
Zurück zum Zitat Tyrrell GJ, Lovgren M, Kress B, Grimsrud K (2005) Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J Clin Microbiol 43:1678–1683CrossRefPubMed Tyrrell GJ, Lovgren M, Kress B, Grimsrud K (2005) Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J Clin Microbiol 43:1678–1683CrossRefPubMed
7.
Zurück zum Zitat Siljander T, Toropainen M, Muotiala A, Hoe NP, Musser JM, Vuopio-Varkila J (2006) emm typing of invasive T28 group A streptococci, 1995–2004, Finland. J Med Microbiol 55:1701–1706CrossRefPubMed Siljander T, Toropainen M, Muotiala A, Hoe NP, Musser JM, Vuopio-Varkila J (2006) emm typing of invasive T28 group A streptococci, 1995–2004, Finland. J Med Microbiol 55:1701–1706CrossRefPubMed
8.
Zurück zum Zitat Siljander T, Karppelin M, Vähäkuopus S, Syrjänen J, Toropainen M, Kere J, Vuento R, Jussila T, Vuopio-Varkila J (2008) Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis 46:855–861CrossRefPubMed Siljander T, Karppelin M, Vähäkuopus S, Syrjänen J, Toropainen M, Kere J, Vuento R, Jussila T, Vuopio-Varkila J (2008) Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis 46:855–861CrossRefPubMed
9.
Zurück zum Zitat Clinical and Laboratory Standards Institute (CLSI) (2007) Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement, M100-S17, vol 27, no 1 Clinical and Laboratory Standards Institute (CLSI) (2007) Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement, M100-S17, vol 27, no 1
10.
Zurück zum Zitat Siljander T, Lyytikäinen O, Vähäkuopus S, Säilä P, Jalava J, Vuopio-Varkila J (2009) Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland. J Clin Microbiol 47:477–480CrossRefPubMed Siljander T, Lyytikäinen O, Vähäkuopus S, Säilä P, Jalava J, Vuopio-Varkila J (2009) Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland. J Clin Microbiol 47:477–480CrossRefPubMed
11.
Zurück zum Zitat Lamagni TL, Efstratiou A, Dennis J, Nair P, Kearney J, George R (2009) Increase in invasive group A streptococcal infections in England, Wales and Northern Ireland, 2008–9. Euro Surveill 14 Lamagni TL, Efstratiou A, Dennis J, Nair P, Kearney J, George R (2009) Increase in invasive group A streptococcal infections in England, Wales and Northern Ireland, 2008–9. Euro Surveill 14
12.
Zurück zum Zitat Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C, Norgren M, Romanus V, Norrby-Teglund A, Normark BH (2007) Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45:450–458CrossRefPubMed Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C, Norgren M, Romanus V, Norrby-Teglund A, Normark BH (2007) Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45:450–458CrossRefPubMed
13.
Zurück zum Zitat Lamagni TL, Neal S, Keshishian C, Alhaddad N, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A (2008) Severe Streptococcus pyogenes infections, United Kingdom, 2003–2004. Emerg Infect Dis 14:202–209CrossRefPubMed Lamagni TL, Neal S, Keshishian C, Alhaddad N, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A (2008) Severe Streptococcus pyogenes infections, United Kingdom, 2003–2004. Emerg Infect Dis 14:202–209CrossRefPubMed
14.
Zurück zum Zitat Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A (2008) Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol 46:79–86CrossRefPubMed Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A (2008) Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol 46:79–86CrossRefPubMed
15.
Zurück zum Zitat O’Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A (2002) Epidemiology of invasive group A streptococcus disease in the United States, 1995–1999. Clin Infect Dis 35:268–276CrossRefPubMed O’Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A (2002) Epidemiology of invasive group A streptococcus disease in the United States, 1995–1999. Clin Infect Dis 35:268–276CrossRefPubMed
16.
Zurück zum Zitat Ekelund K, Darenberg J, Norrby-Teglund A, Hoffmann S, Bang D, Skinhøj P, Konradsen HB (2005) Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol 43:3101–3109CrossRefPubMed Ekelund K, Darenberg J, Norrby-Teglund A, Hoffmann S, Bang D, Skinhøj P, Konradsen HB (2005) Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol 43:3101–3109CrossRefPubMed
17.
Zurück zum Zitat Ikebe T, Hirasawa K, Suzuki R, Ohya H, Isobe J, Tanaka D, Katsukawa C, Kawahara R, Tomita M, Ogata K, Endoh M, Okuno R, Tada Y, Okabe N, Watanabe H (2007) Distribution of emm genotypes among group A streptococcus isolates from patients with severe invasive streptococcal infections in Japan, 2001–2005. Epidemiol Infect 135:1227–1229CrossRefPubMed Ikebe T, Hirasawa K, Suzuki R, Ohya H, Isobe J, Tanaka D, Katsukawa C, Kawahara R, Tomita M, Ogata K, Endoh M, Okuno R, Tada Y, Okabe N, Watanabe H (2007) Distribution of emm genotypes among group A streptococcus isolates from patients with severe invasive streptococcal infections in Japan, 2001–2005. Epidemiol Infect 135:1227–1229CrossRefPubMed
18.
Zurück zum Zitat McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, Dale JB (2005) Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 41:1114–1122CrossRefPubMed McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, Dale JB (2005) Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 41:1114–1122CrossRefPubMed
19.
Zurück zum Zitat Hoe NP, Nakashima K, Lukomski S, Grigsby D, Liu M, Kordari P, Dou SJ, Pan X, Vuopio-Varkila J, Salmelinna S, McGeer A, Low DE, Schwartz B, Schuchat A, Naidich S, De Lorenzo D, Fu YX, Musser JM (1999) Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med 5:924–929CrossRefPubMed Hoe NP, Nakashima K, Lukomski S, Grigsby D, Liu M, Kordari P, Dou SJ, Pan X, Vuopio-Varkila J, Salmelinna S, McGeer A, Low DE, Schwartz B, Schuchat A, Naidich S, De Lorenzo D, Fu YX, Musser JM (1999) Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med 5:924–929CrossRefPubMed
20.
Zurück zum Zitat Muotiala A, Seppälä H, Huovinen P, Vuopio-Varkila J (1997) Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis 175:392–399PubMed Muotiala A, Seppälä H, Huovinen P, Vuopio-Varkila J (1997) Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis 175:392–399PubMed
21.
Zurück zum Zitat Chuang I, Van Beneden C, Beall B, Schuchat A (2002) Population-based surveillance for postpartum invasive group a streptococcus infections, 1995–2000. Clin Infect Dis 35:665–670CrossRefPubMed Chuang I, Van Beneden C, Beall B, Schuchat A (2002) Population-based surveillance for postpartum invasive group a streptococcus infections, 1995–2000. Clin Infect Dis 35:665–670CrossRefPubMed
22.
Zurück zum Zitat Colman G, Tanna A, Efstratiou A, Gaworzewska ET (1993) The serotypes of Streptococcus pyogenes present in Britain during 1980–1990 and their association with disease. J Med Microbiol 39:165–178CrossRefPubMed Colman G, Tanna A, Efstratiou A, Gaworzewska ET (1993) The serotypes of Streptococcus pyogenes present in Britain during 1980–1990 and their association with disease. J Med Microbiol 39:165–178CrossRefPubMed
23.
Zurück zum Zitat Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV (2005) Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003. Clin Infect Dis 41:599–608CrossRefPubMed Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV (2005) Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003. Clin Infect Dis 41:599–608CrossRefPubMed
24.
Zurück zum Zitat Kataja J, Huovinen P, Muotiala A, Vuopio-Varkila J, Efstratiou A, Hallas G, Seppälä H (1998) Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis 177:786–789CrossRefPubMed Kataja J, Huovinen P, Muotiala A, Vuopio-Varkila J, Efstratiou A, Hallas G, Seppälä H (1998) Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis 177:786–789CrossRefPubMed
25.
Zurück zum Zitat Skogberg K, Lyytikäinen O, Ruutu P, Ollgren J, Nuorti JP (2008) Increase in bloodstream infections in Finland, 1995–2002. Epidemiol Infect 136:108–114CrossRefPubMed Skogberg K, Lyytikäinen O, Ruutu P, Ollgren J, Nuorti JP (2008) Increase in bloodstream infections in Finland, 1995–2002. Epidemiol Infect 136:108–114CrossRefPubMed
26.
Zurück zum Zitat Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjänen J (2009) Clinical presentations and epidemiology of beta-haemolytic streptococcal bacteraemia: a population-based study. Clin Microbiol Infect 15:286–288CrossRefPubMed Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjänen J (2009) Clinical presentations and epidemiology of beta-haemolytic streptococcal bacteraemia: a population-based study. Clin Microbiol Infect 15:286–288CrossRefPubMed
Metadaten
Titel
Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland
verfasst von
T. Siljander
O. Lyytikäinen
S. Vähäkuopus
M. Snellman
J. Jalava
J. Vuopio
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 10/2010
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-0989-9

Weitere Artikel der Ausgabe 10/2010

European Journal of Clinical Microbiology & Infectious Diseases 10/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.